CTTC — Calmare Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Calmare Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2012 December 31st	2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.074	0.057	0.006	0.05	0.013
Net Total Accounts Receivable
Net Total Receivables	0.216	0.143	0.002	0.033	0.003
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.73	4.54	4.38	4.17	3.86
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.027	0.008	0.036	0.024	0.007
Other Long Term Assets
Total Assets	4.77	4.57	4.43	4.21	3.88
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.58	10.5	12.1	14.6	17.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	8.8	10.5	12.2	14.6	17.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-4.03	-5.94	-7.74	-10.4	-13.8
Total Liabilities & Shareholders' Equity	4.77	4.57	4.43	4.21	3.88
Total Common Shares Outstanding
Total Preferred Shares Outstanding